Furthermore, its not recommended to take multiple GLP-1 agonists without consulting a healthcare professional, as its unclear how they may interact
Following Roux-en-Y gastric bypass (RYGB) and sleeve gastrectomy (SG), PwO often experience significant declines in bone microarchitecture and strength, as measured by HR-pQCT [37, 38]
PLoS Genet 19 , e1010710 (2023)
[15] GLP-1 has also shown signs of carrying out protective and regulatory effects in numerous other tissues, including heart, tongue, adipose, muscles, bones, kidneys, liver and lungs
Neuropharmacology (2014) 76:5767
While human studies are still limited, the potential of GLP-1 medications to address the neurobiological underpinnings of addiction holds promise for developing novel pharmacological interventions and improving addiction treatment outcomes